The Latin America, Middle East and Africa Autoinjectors Market would witness market growth of 18.7% CAGR during the forecast period (2020-2026).
Epinephrine is considered the first line of treatment for allergic reactions or anaphylaxis. Pharmaceutical companies are bringing technologically advanced epinephrine autoinjectors (EAIs) treatment of anaphylaxis. With the advancement in technology including portable devices, innovative designs, autoinjectors with two auto-injectable doses in one device, autoinjectors made with a 0.5- or 0.75-mg dose of epinephrine for larger adults, the autoinjectors are experiencing higher rate of adoptability.
Also, autoinjectors made with a 0.1-mg dose of epinephrine for infants, autoinjectors with enhanced temperature stability and extended shelf life for epinephrine, weather-resistant casing, and devices that can update patients that the dosage was successfully delivered makes the device more user friendly. Factors that are being focused on for improvement of autoinjectors are removal force of safety cap, override force, ejection time, ejection dosage, needle activation force, needle length, dose setting & audible click detection. These technological advancements are anticipated to drive the adoption of autoinjectors significantly in the coming years.
The existing COVID-19 pandemic has brought about the implementation of a new set of protocols that target to decrease patient visits to hospitals and clinics if it is not emergency conditions in order to prevent the spread of the virus. In such a situation, the inclination for home-use autoinjectors has increased among patients who are suffering from allergies and chronic illnesses. This also safeguards susceptible high-risk populations from exposure to the virus while visiting to hospital.
Autoinjectors are being advanced to support improved concentrations and viscosity of drugs to lessen administration frequency, therefore growing adherence to acclaimed drug protocols. These factors facilitate an opportunity for the growth of the market of autoinjectors in the present COVID-19 scenario.
Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Autoinjectors Market in LAMEA is expected to register a CAGR of 18.7% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Disposable autoinjectors
- Reusable autoinjectors
By Application
- Anaphylaxis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Other Applications
By End Use
- Hospitals & Clinics
- Home care settings
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Eli Lilly and Company
- GlaxoSmithKline PLC (GSK)
- Merck Group
- Sanofi S.A.
- Becton, Dickinson and Company
- Teva Pharmaceuticals Industries Ltd.
- Amgen, Inc.
- Ypsomed AG
- AbbVie, Inc.
- Biogen, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Autoinjectors Market, by Type
1.4.2 LAMEA Autoinjectors Market, by Application
1.4.3 LAMEA Autoinjectors Market, by End Use
1.4.4 LAMEA Autoinjectors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
Chapter 4. LAMEA Autoinjectors Market by Type
4.1 LAMEA Disposable autoinjectors Market by Country
4.2 LAMEA Reusable autoinjectors Market by Country
Chapter 5. LAMEA Autoinjectors Market by Application
5.1 LAMEA Anaphylaxis Market by Country
5.2 LAMEA Rheumatoid Arthritis Market by Country
5.3 LAMEA Multiple Sclerosis Market by Country
5.4 LAMEA Other Application Market by Country
Chapter 6. LAMEA Autoinjectors Market by End Use
6.1 LAMEA Hospitals & Clinics Autoinjectors Market by Country
6.2 LAMEA Home care settings Autoinjectors Market by Country
Chapter 7. LAMEA Autoinjectors Market by Country
7.1 Brazil Autoinjectors Market
7.1.1 Brazil Autoinjectors Market by Type
7.1.2 Brazil Autoinjectors Market by Application
7.1.3 Brazil Autoinjectors Market by End Use
7.2 Argentina Autoinjectors Market
7.2.1 Argentina Autoinjectors Market by Type
7.2.2 Argentina Autoinjectors Market by Application
7.2.3 Argentina Autoinjectors Market by End Use
7.3 UAE Autoinjectors Market
7.3.1 UAE Autoinjectors Market by Type
7.3.2 UAE Autoinjectors Market by Application
7.3.3 UAE Autoinjectors Market by End Use
7.4 Saudi Arabia Autoinjectors Market
7.4.1 Saudi Arabia Autoinjectors Market by Type
7.4.2 Saudi Arabia Autoinjectors Market by Application
7.4.3 Saudi Arabia Autoinjectors Market by End Use
7.5 South Africa Autoinjectors Market
7.5.1 South Africa Autoinjectors Market by Type
7.5.2 South Africa Autoinjectors Market by Application
7.5.3 South Africa Autoinjectors Market by End Use
7.6 Nigeria Autoinjectors Market
7.6.1 Nigeria Autoinjectors Market by Type
7.6.2 Nigeria Autoinjectors Market by Application
7.6.3 Nigeria Autoinjectors Market by End Use
7.7 Rest of LAMEA Autoinjectors Market
7.7.1 Rest of LAMEA Autoinjectors Market by Type
7.7.2 Rest of LAMEA Autoinjectors Market by Application
7.7.3 Rest of LAMEA Autoinjectors Market by End Use
Chapter 8. Company Profiles
8.1 Eli Lilly and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Geographical Expansions:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.1 Recent strategies and developments:
8.2.1.1 Approvals:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Sanofi S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Approvals:
8.4.5.3 Product Launches and Product Expansions:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals:
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expense
8.7.4 Recent strategies and developments:
8.7.4.1 Product Launches and Product Expansions:
8.8 Ypsomed AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AbbVie, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Biogen, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA Autoinjectors Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Autoinjectors Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Auto-Injectors Market
TABLE 4 Product Launches And Product Expansions– Auto-Injectors Market
TABLE 5 Geographical Expansions– Auto-Injectors Market
TABLE 6 Approvals– Auto-Injectors Market
TABLE 7 LAMEA Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 8 LAMEA Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 9 LAMEA Disposable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 10 LAMEA Disposable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 11 LAMEA Reusable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 12 LAMEA Reusable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 13 LAMEA Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 14 LAMEA Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 15 LAMEA Anaphylaxis Market by Country, 2016 - 2019, USD Million
TABLE 16 LAMEA Anaphylaxis Market by Country, 2020 - 2026, USD Million
TABLE 17 LAMEA Rheumatoid Arthritis Market by Country, 2016 - 2019, USD Million
TABLE 18 LAMEA Rheumatoid Arthritis Market by Country, 2020 - 2026, USD Million
TABLE 19 LAMEA Multiple Sclerosis Market by Country, 2016 - 2019, USD Million
TABLE 20 LAMEA Multiple Sclerosis Market by Country, 2020 - 2026, USD Million
TABLE 21 LAMEA Other Application Market by Country, 2016 - 2019, USD Million
TABLE 22 LAMEA Other Application Market by Country, 2020 - 2026, USD Million
TABLE 23 LAMEA Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 24 LAMEA Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 25 LAMEA Hospitals & Clinics Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 26 LAMEA Hospitals & Clinics Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 27 LAMEA Home care settings Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 28 LAMEA Home care settings Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 29 LAMEA Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 30 LAMEA Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 31 Brazil Autoinjectors Market, 2016 - 2019, USD Million
TABLE 32 Brazil Autoinjectors Market, 2020 - 2026, USD Million
TABLE 33 Brazil Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 34 Brazil Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 35 Brazil Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 36 Brazil Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 37 Brazil Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 38 Brazil Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 39 Argentina Autoinjectors Market, 2016 - 2019, USD Million
TABLE 40 Argentina Autoinjectors Market, 2020 - 2026, USD Million
TABLE 41 Argentina Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 42 Argentina Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 43 Argentina Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 44 Argentina Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 45 Argentina Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 46 Argentina Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 47 UAE Autoinjectors Market, 2016 - 2019, USD Million
TABLE 48 UAE Autoinjectors Market, 2020 - 2026, USD Million
TABLE 49 UAE Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 50 UAE Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 51 UAE Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 52 UAE Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 53 UAE Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 54 UAE Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 55 Saudi Arabia Autoinjectors Market, 2016 - 2019, USD Million
TABLE 56 Saudi Arabia Autoinjectors Market, 2020 - 2026, USD Million
TABLE 57 Saudi Arabia Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 58 Saudi Arabia Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 59 Saudi Arabia Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 60 Saudi Arabia Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 61 Saudi Arabia Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 62 Saudi Arabia Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 63 South Africa Autoinjectors Market, 2016 - 2019, USD Million
TABLE 64 South Africa Autoinjectors Market, 2020 - 2026, USD Million
TABLE 65 South Africa Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 66 South Africa Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 67 South Africa Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 68 South Africa Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 69 South Africa Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 70 South Africa Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 71 Nigeria Autoinjectors Market, 2016 - 2019, USD Million
TABLE 72 Nigeria Autoinjectors Market, 2020 - 2026, USD Million
TABLE 73 Nigeria Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 74 Nigeria Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 75 Nigeria Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 76 Nigeria Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 77 Nigeria Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 78 Nigeria Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 79 Rest of LAMEA Autoinjectors Market, 2016 - 2019, USD Million
TABLE 80 Rest of LAMEA Autoinjectors Market, 2020 - 2026, USD Million
TABLE 81 Rest of LAMEA Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 82 Rest of LAMEA Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 83 Rest of LAMEA Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 84 Rest of LAMEA Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 85 Rest of LAMEA Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 86 Rest of LAMEA Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 87 Key Information – Eli Lilly and Company
TABLE 88 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 89 key Information – Merck Group
TABLE 90 Key Information – Sanofi S.A.
TABLE 91 Key information – Becton, Dickinson and Company
TABLE 92 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 93 Key Information – Amgen, Inc.
TABLE 94 Key Information –-Ypsomed AG
TABLE 95 Key information – AbbVie, Inc.
TABLE 96 Key Information – Biogen, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: Sanofi S.A.
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.